Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis Division of Pfizer In NY, NY 10017, NDC 0071-0237-24
Published October 2, 2019 · Recall initiated: September 12, 2019
Summary
FDA records drug Class III recall D-0002-2020, published October 2, 2019 and initiated September 12, 2019. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 7,686 100-count bottles; Lot: Lot #3267079, Exp 09/2021. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.
What to do
Voluntary: Firm initiated · Letter
Get an email if ZARONTIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ZARONTIN
- Manufacturer
- Pfizer Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0300710237247
- Lot
- Lot #3267079, Exp 09/2021
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANatpara (parathyroid hormone) for Injection, 25 mcg/dose, 2 pack cartridges, Rx only, For subcutaneous useOctober 2, 2019
- FDANatpara (parathyroid hormone) for Injection, 100 mcg, 2 pack medication cartridges, Rx only, For subcutaneousOctober 2, 2019
- FDAminolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets,October 2, 2019
- FDAAD-TECH Drill Sleeve Guides, used with Ad-Tech Placement Kits: (a) REF DSG-90-2.3N (b) REF DSG-6.3-090-2.4NSeptember 25, 2019
- FDASubcutaneous Implantable Cardioverter Defibrillator (S-ICD) System, labeled as EMBLEMTM S-ICD Pulse GeneratorSeptember 25, 2019
- FDAPublix 8 inch T/S pumpkin pie US; 623g (22 oz. or 1 LB 6 oz.), Carton, 6 units per caseSeptember 25, 2019
Questions about this recall
Was Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis Division of Pfizer In NY, NY 10017, NDC 0071-0237-24 recalled?
Yes. FDA published recall D-0002-2020 on October 2, 2019. Reported hazard: Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ZARONTIN. UPC: 0300710237247.